POSB197 Impact of Immune Checkpoint Inhibitors (ICIS) on the Management of Advanced Non-Small Cell Lung Cancer (NSCLC) in Real-World Practice at Karolinska University Hospital, Stockholm between 2012 and 2018
Jan 1, 2022, 00:00 AM
10.1016/j.jval.2021.11.635
https://www.valueinhealthjournal.com/article/S1098-3015(21)02430-X/fulltext
Section Title :
Section Order :
10171
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)02430-X&doi=10.1016/j.jval.2021.11.635